Pay in 4 interest-free payments of $37.50 Learn more
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24
C95H151N17O64 / 2371
This compound enables the construction of hepatocyte-targeted therapeutics and research tools that exploit the asialoglycoprotein receptor (ASGPR)
Neu5Acα(2-6)Galβ(1-4)GlcNAcβ(1-3)Galβ(1-4)GlcNAcβ(1-3)Galβ(1-4)GlcNAcβ(1-2)Manα(1-3)[Neu5Acα(2-6)Galβ(1-4)GlcNAcβ(1-3)Galβ(1-4)GlcNAcβ(1-3)Galβ(1-4)GlcNAcβ(1-2)Manα(1-6)]Manβ(1-4)GlcNAcβ(1-4)GlcNAcβ-Asn-PEG8-Biotin
69 / / 25-Hydroxy Vitamin D2-d6 / Ercalcidiol-d6
diagnostic screening
GA821000: Fmoc-Ser((Ac)3-Xyl-β-D)-OH Pack Size:250 mg C95H151N17O64 / 2371C29H31NO12 585. 56 An Fmoc protected L serine building block carrying a D xylose residue, designed for solid phase peptide synthesis (SPPS) of glycopeptides. The N Fmoc group is removed under standard base conditions (piperidine) during chain elongation, while the free carboxylic acid is available for coupling to the growing resin bound peptide. The sugar hydroxyl groups are protected as three acetate esters (Ac3), which keep the glycan inert during
